Meeting
2020 ASCO Virtual Scientific Program
Eradication of medulloblastoma by NKG2D-specific CAR T-cells.
Authors
Hong-jiu Dai
Nanjing Kaedi Biotech Co. Ltd., Nanjing, China
Hong-jiu Dai , Bin Sun , Dong Yang , Hui Xu , Jingjing Zhu , Jia Wei , Xudong Zhao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2522)
DOI
10.1200/JCO.2020.38.15_suppl.2522
Abstract #
2522
Poster Bd #
13
Abstract Disclosures
Similar Posters
First Author: Hong-jiu Dai
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Preliminary biomarker and pharmacodynamic data from a phase I study of single-agent bispecific antibody T-cell engager GBR 1302 in subjects with HER2‑positive cancers.
First Author: Martin Wermke
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Single-cell cytokine profiling of tumor-infiltrating T cells to measure patient responses to anti-PD-1 therapy.
First Author: Sean Mackay
Poster
2016 ASCO Annual Meeting
A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma.
First Author: Sarah Nikiforow